Entera Bio (ENTX) Enterprise Value (2017 - 2026)
Entera Bio (ENTX) recorded quarterly Enterprise Value of -$4.1 million in Q1 2026, up 72.2% on a QoQ basis from -$14.9 million in Q4 2025, and up 67.1% year-over-year from -$2.5 million in Q1 2025.
Entera Bio (ENTX) Enterprise Value (2017 - 2026) Analysis & Trends
Entera Bio has disclosed Enterprise Value across 9 years of filings, most recently posting -$4.1 million for Q1 2026.
- Quarterly Enterprise Value rose 67.1% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.1 million (up 67.1% YoY) and the FY2025 annual result came in at -$14.9 million, down 71.86% from the prior year.
- Enterprise Value improved to -$4.1 million in Q1 2026, from -$14.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$4.1 million in Q1 2026 and troughed at -$20.1 million in Q1 2022.
- A 5-year average of -$11.0 million and a median of -$10.7 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value tumbled 71.86% — and 2026, when it surged 67.1%.
- Tracing ENTX's Enterprise Value over 5 years: stood at -$12.3 million in 2022, then rose by 10.48% to -$11.0 million in 2023, then gained by 21.41% to -$8.7 million in 2024, then slumped by 71.86% to -$14.9 million in 2025, then soared by 72.2% to -$4.1 million in 2026.
- Business Quant data shows ENTX's Enterprise Value at -$4.1 million in Q1 2026, -$14.9 million in Q4 2025, and -$8.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -584.73 Mn |
| 10 | Entera Bio | 57.79 Mn | 53.65 Mn | - | -4.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.14 Mn |
| Dec 31, 2025 | -14.88 Mn |
| Sep 30, 2025 | -8.57 Mn |
| Jun 30, 2025 | -10.86 Mn |
| Mar 31, 2025 | -12.57 Mn |
| Dec 31, 2024 | -8.66 Mn |
| Sep 30, 2024 | -6.92 Mn |
| Jun 30, 2024 | -9.06 Mn |
| Mar 31, 2024 | -9.19 Mn |
| Dec 31, 2023 | -11.02 Mn |
| Sep 30, 2023 | -7.59 Mn |
| Jun 30, 2023 | -9.14 Mn |
| Mar 31, 2023 | -10.69 Mn |
| Dec 31, 2022 | -12.31 Mn |
| Sep 30, 2022 | -14.32 Mn |
| Jun 30, 2022 | -17.28 Mn |
| Mar 31, 2022 | -20.11 Mn |
| Dec 31, 2021 | -24.89 Mn |
| Sep 30, 2021 | -27.40 Mn |
| Jun 30, 2021 | -26.93 Mn |